Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc

Bullboard Posts

Comment by 2skytracker2on Mar 28, 2012 2:26pm

439 Views

Post# 19729137

RE: RE: Bought More This Morning!!!

I cant qualify .25 at this point, howerver based on cash flow alone from these 2 wells ( and they are no screaming hll) This stock is about 30% of were it should be right now, and if by some mericle mani#1 gets back to were it was then SP is worth more again. Call me optimistic but I believe there is more oil to come this year and you may be right but I dont think we will see .03,........I think we go up now.....at this level I buy and hold.

Bullboard Posts

Canadian psychedelic stock to supply MDMA to Yale